Hydroxylation Increases the Neurotoxic Potential of BDE-47 to Affect Exocytosis and Calcium Homeostasis in PC12 Cells by Dingemans, Milou M.L. et al.
Increasing concentrations of brominated
ﬂame retardants, in particular polybrominated
diphenyl ethers (PBDEs), in the environment,
human food chain, and human tissues raise
concern about possible neurotoxic effects.
High concentrations of PBDEs and the struc-
turally related polychlorinated biphenyls
(PCBs) increase intracellular Ca2+ concentra-
tions ([Ca2+]i) in cultured neuronal cells,
likely through mobilizing Ca2+ from intracel-
lular stores (for review, see Mariussen and
Fonnum 2006). Such a xenobiotic-induced
increase in [Ca2+]i is of particular concern
because this increase, in addition to being
essential for multiple physiologic and patho-
logic processes, is the trigger for vesicular
release of neurotransmitters (exocytosis). This
correlation between increased [Ca2+]i and the
occurrence of exocytosis has been widely stud-
ied in neurons (for review, see Barclay et al.
2005) and neuroendocrine cells, including rat
pheochromocytoma PC12 cells (for review,
see Garcia et al. 2006). Evidence of oxidative
metabolism of PBDEs is accumulating, but
the neurotoxic potential of hydroxylated
PBDE metabolites and their ability to affect
Ca2+ homeostasis is still unknown.
In most biotic samples, 2,2´,4,4´-tetra-
bromodiphenyl ether (BDE-47) is the pre-
dominant PBDE congener (Hites et al. 2004).
Neonatal exposure to this PBDE congener
induces neurobehavioral changes (Eriksson
et al. 2001b) and reduces long-term potentia-
tion (LTP) in mouse hippocampal slices
(Dingemans et al. 2007). Analysis of brain tis-
sue from BDE-47–exposed mice revealed that
alterations in the composition of postsynaptic
density proteins and kinase activity might play
a role in the reduction of synaptic plasticity
(Dingemans et al. 2007). The doses of
BDE-47 resulting in impaired learning and
memory and reduced LTP measured in hip-
pocampal slices were estimated (using a distri-
bution study; Staskal et al. 2006a) to result in
peak brain concentrations of approximately
1 µM, whereas acute toxic effects of BDE-47
were seen in vitro only at concentrations rang-
ing from 3 to 20 µM (Coburn et al. 2008;
Dingemans et al. 2007).
The results of in vitro endocrine studies
(focusing mostly on 6-hydroxy-2,2´,4,4´-
tetrabromodiphenyl ether; 6-OH-BDE-47)
on interactions with the estrogen and thyroid
hormone receptor systems indicate that
hydroxylated metabolites of PBDEs are more
potent than the parent compounds (Cantón
et al. 2005, 2006; Harju et al. 2007; Meerts
et al. 2001). The conversion of PBDEs to
hydroxylated metabolites was confirmed by
recent toxicokinetics studies (Huwe et al. 2006;
Malmberg et al. 2005; Marsh et al. 2005;
Staskal et al. 2006b). Additionally, marine
sponges can produce ortho-OH-PBDEs (Hakk
and Letcher 2003). Hydroxylated metabolites
have been detected in blood from wildlife and
humans (for review, see Hakk and Letcher
2003). Therefore, we investigated the effects of
6-OH-BDE-47, a hydroxylated metabolite of
the environmentally relevant PBDE congener
BDE-47, on Ca2+ homeostasis and vesicular
catecholamine release in PC12 cells to com-
pare its neurotoxic potential with that of the
parent compound. 
Methods
Chemicals. BDE-47 and 6-OH-BDE-47
were synthesized and puriﬁed (~ 99% purity)
at the Wallenberg Laboratory of Stockholm
University as described by Marsh et al.
(1999). Dibenzo-p-dioxins and dibenzofurans
were removed from the PBDEs with a char-
coal column as described by Örn et al.
(1996). All other chemicals, unless otherwise
stated, were obtained from Sigma-Aldrich
(Zwijndrecht, the Netherlands).
Cell culture. Rat pheochromocytoma
(PC12) cells (Greene and Tischler 1976)
obtained from the ATCC (American Type
Culture Collection, Manassas, VA, USA) were
cultured for up to 15 passages in RPMI 1640
medium (Invitrogen, Breda, the Netherlands)
supplemented with 5% fetal calf serum and
10% horse serum (ICN Biomedicals,
Zoetermeer, the Netherlands). For Ca2+ imag-
ing experiments, we subcultured undifferenti-
ated PC12 cells in poly-L-lysine–coated
glass-bottom dishes (MatTek, Ashland, MA,
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BACKGROUND: Oxidative metabolism, resulting in the formation of hydroxylated polybrominated
diphenyl ether (PBDE) metabolites, may enhance the neurotoxic potential of brominated flame
retardants.
OBJECTIVE: Our objective was to investigate the effects of a hydroxylated metabolite of 2,2´,4,4´-tetra-
bromodiphenyl ether (BDE-47; 6-OH-BDE-47) on changes in the intracellular Ca2+ concentration
([Ca2+]i) and vesicular catecholamine release in PC12 cells.
METHODS: We measured vesicular catecholamine release and [Ca2+]i using amperometry and imag-
ing of the ﬂuorescent Ca2+-sensitive dye Fura-2, respectively.
RESULTS: Acute exposure of PC12 cells to 6-OH-BDE-47 (5 µM) induced vesicular catecholamine
release. Catecholamine release coincided with a transient increase in [Ca2+]i, which was observed
shortly after the onset of exposure to 6-OH-BDE-47 (120 µM). An additional late increase in
[Ca2+]i was often observed at ≥ 1 µM 6-OH-BDE-47. The initial transient increase was absent in
cells exposed to the parent compound BDE-47, whereas the late increase was observed only at
20 µM. Using the mitochondrial uncoupler carbonyl cyanide 4-(triﬂuoromethoxy)phenylhydrazone
(FCCP) and thapsigargin to empty intracellular Ca2+ stores, we found that the initial increase origi-
nates from emptying of the endoplasmic reticulum and consequent influx of extracellular Ca2+,
whereas the late increase originates primarily from mitochondria. 
CONCLUSION: The hydroxylated metabolite 6-OH-BDE-47 is more potent in disturbing Ca2+
homeostasis and neurotransmitter release than the parent compound BDE-47. The present ﬁndings
indicate that bioactivation by oxidative metabolism adds considerably to the neurotoxic potential of
PBDEs. Additionally, based on the observed mechanism of action, a cumulative neurotoxic effect of
PBDEs and ortho-substituted polychlorinated biphenyls on [Ca2+]i cannot be ruled out. 
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ResearchUSA) as described previously (Dingemans
et al. 2007). For amperometric recordings, the
cells were differentiated for 3–5 days with
5 µM dexamethasone to enhance exocytosis,
as described previously by Westerink and
Vijverberg (2002).
Cell viability assay. We used cell density
as an indicator of cell viability. After 20 min
of exposure to dimethylsulfoxide (DMSO) or
20 µM 6-OH-BDE-47, cells were cultured in
fresh cell culture medium for another 24 hr.
After replacing the culture medium, which
washes away most dead, detached cells, and
trypan blue inclusion, which stains the
remaining dead cells, we determined the pro-
portion of the surface of the cell culture dish
occupied by living PC12 cells in triplicate for
three dishes per experimental condition.
Amperometry. Amperometric recordings
of K+-evoked and spontaneous vesicular
catecholamine release from dexamethasone-
differentiated PC12 cells using carbon fiber
microelectrodes were made as described previ-
ously (Dingemans et al. 2007; Westerink and
Vijverberg 2002). Following 1 min of base-
line recording, we superfused PC12 cells for
15 sec with high K+-containing saline (K+
increased to 125 mM and Na+ lowered to
5.5 mM) to determine their responsiveness.
Cells were allowed to recover for 2 min before
a 15-min exposure to BDE-47 or 6-OH-
BDE-47 to investigate acute effects on vesicu-
lar catecholamine release. Recordings were
performed at room temperature. To ensure
exclusion of nonresponsive or extraordinary
cells, we determined basal release frequency
for 22 cells. Cells that showed a basal release
frequency larger than the average + 2 standard
deviations were considered to have an extraor-
dinary high release frequency. Based on these
ﬁndings, we excluded cells with a basal release
frequency > 5/min. Similarly, cells with an
evoked release frequency < 16/min were
excluded. We used the resulting 20 cells for
further data analysis.
Intracellular Ca2+ imaging. We measured
changes in [Ca2+]i using the Ca2+-responsive
ﬂuorescent ratio dye Fura-2 as described previ-
ously (Dingemans et al. 2007). Briefly, cells
were loaded with 5 µM Fura-2 AM (Molecular
Probes; Invitrogen) in external saline (con-
taining 1.8 mM CaCl2, 24 mM glucose,
10 mM HEPES, 5.5 mM KCl, 0.8 mM
MgCl2, 125 mM NaCl, and 36.5 mM
sucrose, adjusted to pH 7.3 with NaOH) for
20 min at room temperature; this was fol-
lowed by 15 min de-esteriﬁcation in external
saline. The cells were then placed on the stage
of an Axiovert 35M inverted microscope
(Zeiss, Göttingen, Germany) equipped with a
TILL Photonics Polychrome IV (TILL
Photonics GmBH, Gräfelfing, Germany).
Fluorescence evoked by 340 and 380 nm
excitation wavelengths (F340 and F380) was
recorded every 12 sec at 510 nm with an
Image SensiCam digital camera (TILL
Photonics GmBH). The digital camera and
polychromator were controlled by imaging
software (TILLvisION, version 4.01),
which was also used for data collection and
processing. We further analyzed changes in
the F340/F380 ratio, reflecting changes in
[Ca2+]i, using custom-made Excel macros
(Microsoft Corp., Redmond, WA, USA).
After 5 min baseline recording, cells were
exposed to 0.2–20 µM BDE-47 or 6-OH-
BDE-47. Maximum and minimum ratios
were determined after 25 min recording
(20 min exposure) by addition of ionomycin
(5 µM) and ethylenediamine tetraacetic acid
(EDTA; 17 mM) as a control for experimental
conditions.
Where applicable, cells were washed with
Ca2+-free external saline (containing 10 µM
EDTA to remove residual extracellular Ca2+)
just before the imaging experiments. In spe-
cific experiments, intracellular Ca2+ stores
were emptied by incubation with 1 µM thap-
sigargin (TG) and 1 µM carbonyl cyanide
4-(trifluoromethoxy)phenylhydrazone
(FCCP) in Ca2+-free external saline for
10 min. FCCP depolarizes the mitochondrial
membranes, resulting in the uncoupling of
oxidative phosphorylation and subsequent
Ca2+ release from mitochondria (Taylor et al.
2000). TG is a high-affinity inhibitor of
sarcoplasmic/endoplasmic reticulum (ER)
Ca2+ ATPase (SERCA). These compounds
are commonly used under experimental con-
ditions to empty intracellular Ca2+ stores
(Toyoshima and Inesi 2004). To further dis-
tinguish between direct effects on ER and
Ca2+ inﬂux pathways, we used dantrolene as
an inhibitor of Ca2+ release from the ER.
Data analysis and statistics. To determine
effects on [Ca2+]i, we used the normalized
F340/F380 ratio. Any change in the normal-
ized ratios to ≥ 1.1 was considered an increase
and was used for further data analysis. We
refer to a transient increase in [Ca2+]i reaching
its peak value (amplitude) between 0 and
4.5 min after application as an initial increase.
We consider an additional increase after cessa-
tion of the initial transient increase to be a
late increase. In a number of experiments
(4/33), the initial fast transient was absent,
and instead, a slower transient increase was
observed. Because it is unclear whether this
was a delayed initial transient increase or a
transient form of the late increase, we
excluded these experiments from further
analysis. All data are presented as mean ± SE
from the number of cells indicated. Statistical
analyses were performed using SPSS 12.0.1
(SPSS, Chicago, IL, USA). Categorical data
were compared using Fisher’s exact and chi-
square tests. We compared continuous data
using Student’s t-test, paired or unpaired
where applicable. Analysis of variance
(ANOVA) and post hoc t-tests (corrected for
multiple comparisons) were performed to
investigate possible dose–response relation-
ships. A p-value < 0.05 was considered statis-
tically signiﬁcant. 
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Figure 1. Catecholamine release in PC12 cells exposed to DMSO (n = 9) or 5 µM 6-OH-BDE-47 (n = 11)
shown as the cumulative average number of released vesicles (A). Results clearly demonstrate that 6-OH-
BDE-47 induced exocytosis. (B) Representative amperometric traces recorded from cells exposed to
DMSO or 5 µM 6-OH-BDE-47. 
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6-OH-BDE-47 increases catecholamine
release in PC12 cells. Exposure of PC12 cells
to a high concentration (20 µM) of the bromi-
nated ﬂame retardant BDE-47 was previously
shown to induce vesicular catecholamine
release, coinciding with a gradual increase in
[Ca2+]i (Dingemans et al. 2007). To investi-
gate whether oxidative metabolism changes
the ability of PBDEs to affect vesicular cate-
cholamine release, we measured the effects of
6-OH-BDE-47, a hydroxylated metabolite of
BDE-47. Although cytotoxicity has been
reported after subchronic exposure (24 hr) to
2.5 µM 6-OH-BDE-47 (Cantón et al. 2005),
20 min of exposure to 20 µM 6-OH-BDE-47
did not have any effects on cell viability deter-
mined 24 hr later, suggesting the absence of
acute cell toxicity (data not shown).
To investigate whether exposure to
6-OH-BDE-47 has functional consequences
for neuronal communication, we measured
vesicular catecholamine release (Figure 1).
First, cells were challenged for 15 sec with
high K+-containing saline to determine their
responsiveness. Responsive cells displayed
depolarization-evoked release (at least
16 released vesicles/min), after which the
release frequency returned to baseline values.
During the first 2.5 min of a subsequent
exposure to 5 µM 6-OH-BDE-47 (n = 9),
the release frequency was enhanced from
1.0 ± 0.3 to 13 ± 5.3 events/min (p < 0.05).
This enhancement did not occur in cells
exposed to DMSO only (from 1.8 ± 0.5 to
1.7 ± 0.7 events/min, not signiﬁcant; n = 11).
After the burst of exocytotic activity, the
release frequency in 6-OH-BDE-47–exposed
cells declined to a value not signiﬁcantly dif-
ferent from basal release.
6-OH-BDE-47 causes a biphasic increase
in [Ca2+]i in PC12 cells. To investigate
whether the observed changes in neurotrans-
mitter release are caused by a disruption of cal-
cium homeostasis, we measured the effects of
6-OH-BDE-47 on the [Ca2+]i. Exposure of
PC12 cells to 6-OH-BDE-47 (≥ 1µ M )
resulted in a dose-dependent increase in
[Ca2+]i in PC12 cells (Figures 2 and 3),
whereas exposure to similar concentrations of
the parent compound had no effects on
[Ca2+]i (Figure 2) (Dingemans et al. 2007).
The parent compound BDE-47 caused a grad-
ual increase of [Ca2+]i only at 20 µM (data not
shown; Dingemans et al. 2007), whereas expo-
sure to 1 µM of the hydroxylated metabolite
resulted in an initial transient increase in
[Ca2+]i (Figures 2 and 3). At concentrations
≥ 1 µM, 6-OH-BDE-47 also caused an addi-
tional late increase in [Ca2+]i (Figures 2
and 3). The relative occurrences (percentages
of cells showing an effect) of initial transient
and late increases in [Ca2+]i increased with
increasing concentrations of 6-OH-BDE-47
(Figure 3). Exposure to vehicle or 0.1 or
0.2 µM 6-OH-BDE-47 had no significant
effect on [Ca2+]i (Figure 3).
Exposure to 20 µM 6-OH-BDE-47
caused a large initial transient increase in
[Ca2+]i (1.7 ± 0.1), and an even larger late
increase (3.2 ± 0.4) compared to the normal-
ized baseline. At this high concentration, non-
speciﬁc effects are likely to occur. Therefore,
we investigated the concentration dependence
of the amplitude of the two types of increases
in [Ca2+]i within the range of 1 µM (the low-
est concentration where the effects occur) to
5 µM. ANOVA analysis indicated no relation-
ship between the applied 6-OH-BDE-47 con-
centration and the amplitude of the initial
Ca2+ transient (Figure 4A). Analysis of the late
increase indicated that the amplitude of
this increase is concentration dependent
(Figure 4B), although the biologic relevance of
this small change remains to be determined.
The distinct temporal aspects combined with
this observation on the concentration depen-
dence suggest that distinct mechanisms under-
lie both phases of increasing [Ca2+]i.
6-OH-BDE-47–induced increase in [Ca2+]i
mainly originates from intracellular stores. To
investigate the mechanisms underlying the
observed increase in [Ca2+]i, we performed
Ca2+ imaging experiments under Ca2+-free
conditions to reveal whether extracellular Ca2+
is required. Both the initial transient and the
additional late increase in [Ca2+]i were still pre-
sent under Ca2+-free conditions. However, the
BDE-47 strongly affects Ca2+ after hydroxylation
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Figure 2. Biphasic increase in [Ca2+]i in PC12 cells after exposure to 6-OH-BDE-47. Results are shown as
representative traces of normalized F340/F380 (reflecting [Ca2+]i) from individual PC12 cells exposed to
2 µM BDE-47 and 1, 2, 5, and 20 µM 6-OH-BDE-47 for 20 min, applied at t = 0, as indicated. Note the differ-
ence in scaling for 2 µM BDE-47 and 20 µM 6-OH-BDE-47. 
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2 μM 6-OH-BDE-47 exposureoccurrence and amplitude of the initial increase
were significantly higher under physiologic
Ca2+ conditions (1.8 mM; Figures 5 and 6).
The occurrence and amplitude of late increases
were not altered under Ca2+-free conditions
(Figures 5 and 6). From these data, we con-
clude that the initial increase depends only par-
tially on extracellular Ca2+, whereas the late
increase is independent of external Ca2+, indi-
cating that the 6-OH-BDE-47–induced
increase in [Ca2+]i largely relies on the release
of Ca2+ from intracellular stores.
To identify the intracellular stores responsi-
ble for the observed increase in [Ca2+]i, we per-
formed additional Ca2+ imaging experiments
using PC12 cells in which mitochondrial and
TG-sensitive intracellular Ca2+ stores were
depleted by pretreatment with FCCP and TG,
respectively. After depletion of ER Ca2+ stores
with TG under Ca2+-free conditions, 5 µM
6-OH-BDE-47 was no longer able to evoke
the initial transient increase in [Ca2+]i, but the
late increase was still present (Figure 5). Both
the occurrence and the amplitude of the late
increase were larger after TG pretreatment
compared with normal and Ca2+-free condi-
tions (Figure 6), indicating a tight coupling
between intracellular Ca2+ stores. After deple-
tion of both mitochondrial and ER Ca2+ stores
with FCCP and TG under Ca2+-free condi-
tions, both the initial transient and the late
increase in [Ca2+]i were completely absent.
These combined data indicate that the initial
transient increase in [Ca2+]i, which depends
only partly on Ca2+ inﬂux, is mainly caused by
intracellular Ca2+ release from the ER, whereas
the late increase is mainly due to Ca2+ release
from mitochondria.
To investigate whether the inﬂux of extra-
cellular Ca2+ in the initial transient increase
was related to emptying of the ER, we exposed
dantrolene (100 µM)-pretreated PC12 cells to
5 µM 6-OH-BDE-47 under physiologic Ca2+
conditions. The occurrence and amplitude of
the initial transient increase were markedly
reduced under these conditions (data not
shown), suggesting that store-operated Ca2+
entry (SOCE) largely accounts for the inﬂux of
extracellular Ca2+.
Discussion
The results of the present study demonstrate
that both the abundant PBDE congener
BDE-47 and its hydroxylated metabolite 6-
OH-BDE-47 increase [Ca2+]i in PC12 cells,
although the hydroxylated metabolite does so
at much lower concentrations. The initial tran-
sient and the late increase in [Ca2+]i are due to
release of Ca2+ from endoplasmic and mito-
chondrial Ca2+ stores, respectively; extracellular
Ca2+ also plays a role in the observed initial
increase in [Ca2+]i during exposure to 6-OH-
BDE-47. Interestingly, the initial increase in
[Ca2+]i is temporally linked with vesicular cate-
cholamine release, raising concern about effects
of BDE exposure on neurotransmission.
The increase in [Ca2+]i is mainly caused
by release of Ca2+ from intracellular stores,
which are involved in controlling intracellular
Ca2+ homeostasis and neurotransmitter
release (for review, see Garcia et al. 2006). It
is noteworthy that disruption of intracellular
Ca2+ homeostasis by release of Ca2+ from
intracellular stores and inﬂux of extracellular
Ca2+ is also considered an important factor in
the neurotoxicity of PCBs (for review, see
Fonnum et al. 2006; Kodavanti 2005).
The effects of 6-OH-BDE-47 on exo-
cytosis and [Ca2+]i have been investigated in
PC12 cells, which are widely used as an in vitro
neuroendocrine model to study neurotransmit-
ter secretion (for review, see Westerink and
Ewing 2008). Possible origins for the 6-OH-
BDE-47–induced increase in [Ca2+]i are inﬂux
of extracellular Ca2+ or release from intracellu-
lar Ca2+ stores. In adrenal chromaffin and
PC12 cells, intracellular Ca2+ stores are ER,
mitochondria, nucleus, and secretory vesicles.
Influx via voltage-gated Ca2+ channels and
SOCE channels, and efﬂux from the ER and
the mitochondria, are tightly coupled and
locally control the [Ca2+]i that regulates exo-
cytosis (for review, see Garcia et al. 2006;
Parekh and Putney 2005). The increase in
[Ca2+]i following exposure to 6-OH-BDE-47
is also associated with an increase in vesicular
catecholamine release in PC12 cells. The
increase in catecholamine release was most
apparent during the ﬁrst 2.5 min of exposure,
whereas release frequencies were no longer
Dingemans et al.
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Figure 3. Concentration dependence of the occurrence of different types of [Ca2+]i disturbances during expo-
sure to 6-OH-BDE-47. Bars indicate the percentage of cells showing an initial transient increase in [Ca2+]i or
those showing a late increase in [Ca2+]i. For both processes, the percentage of cells displaying an increase is
signiﬁcantly higher than in control at concentrations ≥ 1 µM (initial: p < 0.001; late: p < 0.01). Data are shown
from three to eight experiments per concentration; numbers above each bar indicate the number of cells
used for data analysis. Inset: representative recording with the characteristics of the increase in [Ca2+]i used
in this article (i.e., amplitude of the initial and late increase in [Ca2+]i). 
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Figure 4. Amplitude of the initial and late increase in [Ca2+]i after exposure to 1–5 µM 6-OH-BDE-47 shown
as boxplots of amplitudes reached during the initial transient (A) and late increase (B). Upper and lower
borders of the box represent upper and lower quartiles; the line within the box is the median; whiskers
represent lowest and highest values, and circles represent outliers. ANOVA analysis indicates no differ-
ences in the amplitude of the initial increase at different concentrations (p > 0.05). ANOVA analysis and
post-hoc t-tests indicate that the amplitude of the late increase in [Ca2+]i increases with increasing con-
centration (p < 0.01). Data shown are from three to eight experiments per concentration; numbers above
each box indicate the number of cells used for data analysis. 
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**different between control cells and cells
exposed to 6-OH-BDE-47 after 5 min of
exposure (Figure 1). The strong temporal link
between the 6-OH-BDE-47–induced initial
transient increase in [Ca2+]i (by emptying of
the ER and subsequent SOCE) and the 6-OH-
BDE-47–induced burst of exocytotic activity
strongly suggests a causal relationship. Because
the observed late increase in [Ca2+]i (by Ca2+
release from mitochondria) has a smaller effect
on [Ca2+]i than the emptying of the ER and
subsequent SOCE (Figure 4) at concentrations
< 5 µM, the association between this late
increase in [Ca2+]i and neurotransmitter release
is likely to be of less toxicologic concern.
Because the initial peak is completely
absent in TG-treated cells, we concluded that
this increase in [Ca2+]i primarily originates
from the ER. Another brominated ﬂame retar-
dant (tetrabromobisphenol A) has recently
been shown to be a potent inhibitor of the
SERCA Ca2+ pump (Ogunbayo and
Michelangeli 2007). The reduced amplitude
of the initial transient [Ca2+]i increase under
Ca2+-free conditions (without TG pre-
treatment) indicates that both an intracellular
and extracellular Ca2+ component contribute
to this transient increase. The extracellular
Ca2+ component could be caused by a direct
effect of 6-OH-BDE-47. However, the TG
experiments suggest it is more likely that
SOCE, through SOCE channels, in response
to 6-OH-BDE-47–induced emptying of the
ER, accounts for the involvement of extra-
cellular Ca2+. SOCE is commonly observed in
PC12 cells after depletion of Ca2+ stores
(Bennett et al. 1998; Taylor and Peers 1999).
When Ca2+ release from the ER is inhibited by
dantrolene during exposure to 6-OH-BDE-47,
the initial transient increase is markedly
reduced, suggesting that a large part of the
extracellular component is indeed an indirect
effect of 6-OH-BDE-47 associated with
SOCE. However, as a small initial transient
increase can still be observed, it is not possible
at present to exclude a direct effect of 6-OH-
BDE-47 on other Ca2+ inﬂux pathways.
In cells treated with TG and the mitochon-
drial uncoupler FCCP, both the initial and the
late increase no longer occur after application of
6-OH-BDE-47. As the initial increase was
already abolished by TG, these results indicate
that the late increase in [Ca2+]i mainly origi-
nates from mitochondria. In TG-treated cells,
the amplitude of the late Ca2+ increase is larger
(Figure 6). A possible explanation for this
enhancement of the late Ca2+ increase is the
tight coupling between Ca2+ inﬂux via voltage-
gated and SOCE channels and efflux from
intracellular stores (for review, see Garcia et al.
2006; Parekh and Putney 2005). This coupling
predicts that mitochondria take up Ca2+ from
the emptied TG-sensitive stores and will thus
be ﬁlled to a larger extent. As a consequence,
emptying of mitochondrial stores by 6-OH-
BDE-47 will result in an enhancement of the
late Ca2+ increase (Figure 6).
The present ﬁndings add to previous stud-
ies demonstrating that ortho-substituted (non-
planar) PCBs increase [Ca2+]i in cultured
neural cells and brain preparations (Howard
et al. 2003; Ingleﬁeld and Shafer 2000; Kang
et al. 2004; Kodavanti et al. 1993; Magi et al.
2005; Voie and Fonnum 1998; Wong et al.
1997). Inhibition of endoplasmic and mito-
chondrial Ca2+-ATPases, mobilization of Ca2+
from the ER through interaction with the
inositol triphosphate (IP3)- and ryanodine
receptors, and disruption of plasma, mito-
chondrial, and endoplasmic membranes have
all been proposed as possible mechanisms.
Furthermore, the commercial PBDE mixture
DE-71, which contains 31.8% BDE-47, has
also been shown to disrupt microsomal Ca2+
homeostasis (Kodavanti and Ward 2005).
More recently, a gradual increase in [Ca2+]i in
PC12 cells has also been reported for the envi-
ronmentally relevant BDE-47, although only
at 20 µM (Dingemans et al. 2007). Also,
BDE-47, as well as 2,2´,4,4´,5-pentabromo-
diphenyl ether (BDE-99), result in a reduced
net Ca2+ uptake by microsomes and mito-
chondria isolated from frontal cortex, cerebel-
lum, hippocampus, and hypothalamus of
adult male rats measured after 20 min expo-
sure to 3–30 µM (Coburn et al. 2008).
The underlying mechanisms of the
(hydroxylated) PBDE-induced disruption of
Ca2+ homeostasis should be investigated in
more detail. Increasing evidence suggests that
formation of reactive oxygen species (ROS)
could be responsible for the observed effects
on [Ca2+]i. In rat hippocampal neurons as well
as in human SH-SY5Y cells and neutrophil
granulocytes, BDE-47 has been shown to
induce ROS formation at exposure concentra-
tions of 41, 4, and 6 µM, respectively (He
et al. 2008a, 2008b; Reistad and Mariussen
2005). However, the effect of hydroxylated
BDE-47 on ROS formation remains to be
determined. Mechanisms usually associated
with increased ROS formation include activa-
tion of tyrosine kinase, IP3-kinase, protein
kinase C, phospholipase C, and nicotinamide
adenine dinucleotide phosphate (NADPH)
oxidase; release of arachidonic acid; and dis-
turbed and increased [Ca2+]i (Kodavanti and
Derr-Yellin 2002; Kodavanti and Ward 2005;
BDE-47 strongly affects Ca2+ after hydroxylation
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Figure 5. Release from intracellular Ca2+ stores in PC12 cells after exposure to 6-OH-BDE-47. Results are
shown as representative traces of [Ca2+]i measurements of individual PC12 cells exposed to 5 µM 6-OH-
BDE-47 (applied at t = 0; dashed line) in external saline (containing 1.8 mM Ca2+) and under Ca2+-free con-
ditions as indicated for each panel. The initial transient increase is smaller under Ca2+-free conditions
(note the different scale). When cells were pretreated with TG or TG + FCCP, an immediate increase in
[Ca2+]i, corresponding to the emptying of intracellular stores, can be seen. Upon subsequent exposure to
6-OH-BDE-47, the initial transient increase, as observed under control conditions, is absent. Only in cells
pretreated with TG and FCCP is the 6-OH-BDE-47–induced late increase also absent.
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–10 –8 –6 –4 –2 0 2 4 6 8 10Reistad and Mariussen 2005). Because of the
ether group connecting the phenyl rings in
PBDEs, these compounds display a structural
resemblance with ortho-substituted PCBs. It is
therefore likely that disruption of Ca2+ home-
ostasis (for review, see Mariussen and Fonnum
2006), primarily caused by Ca2+ release from
intracellular stores, is a common feature under-
lying the neurotoxicity of both ortho-PCBs and
PBDEs.
Determination of the relative potency of
6-OH-BDE-47 and BDE-47 based on half
maximal effective concentrations requires full
dose–response curves with similar slopes and
efﬁcacy, which is not realistic due to the occur-
rence of nonspeciﬁc effects at high concentra-
tions of 6-OH-BDE-47 and the relatively low
potency of the parent compound and conse-
quent solubility problems. Nonetheless, com-
parison of lowest observed effect concentrations
clearly reveals that 6-OH-BDE-47 has a
potency at least one order of magnitude higher
than the parent compound BDE-47.
In the 1990s, an association between
delayed human neurodevelopment and prenatal
or neonatal exposure to PCBs was reported in
cohort studies, which were corroborated by
experiments demonstrating developmental neu-
rotoxicity of PCBs (for review, see Winneke
et al. 2002). Although epidemiologic evidence
for a similar association of PBDEs is yet lack-
ing, it has been established that exposure of
mice to these environmental pollutants during
brain development can cause toxic effects at
doses much lower than those affecting adult
brain function (Eriksson et al. 2001a). It is thus
of particular concern that young children at
critical stages of brain development are exposed
to higher concentrations of PBDEs than adults.
This high exposure is mainly associated with an
increased exposure of children to house dust,
which is an important source of PBDEs (Jones-
Otazu et al. 2005). Additionally, global differ-
ences in PBDE body burden are observed, with
average levels in North America being approxi-
mately 10 times higher than in Europe and Asia
(Birnbaum and Cohen Hubal 2006). Very high
serum concentrations of BDE-47 (as well as
other PBDE congeners) have recently been
measured in children working and living on a
waste dumpsite in Nicaragua (Athanasiadou
et al. 2008). These samples also have shown
that hydroxylated PBDE metabolites bioaccu-
mulate in human serum. The highest concen-
tration of 6-OH-BDE-47 measured was
13 pmol/g lipid weight, corresponding to
approximately 0.14 nM in blood (calculated
using average physiologic values). These in vivo
values are still orders of magnitude lower than
those that exert effects in the present in vitro
study. However, particular concern about neu-
rotoxicity arises from the fact that comparable
or even higher levels were observed for several
other hydroxylated PBDE metabolites, for
which even fewer toxicity data are available
than for 6-OH-BDE-47.
In summary, exposure of PC12 cells to
≥ 1 µM 6-OH-BDE-47 increases exocytosis
and [Ca2+]i, mainly via release from ER and
mitochondria, whereas its parent compound
BDE-47 causes comparable effects only at
20 µM. Furthermore, recent in vivo ﬁndings
demonstrated that neonatal exposure of mice
to BDE-47 causes permanent effects on
neurobehavior (Eriksson et al. 2001b) and
synaptic plasticity (Dingemans et al. 2007).
Human exposure to hydroxylated PBDE
metabolites results from uptake from natural
sources and from internal oxidative metabo-
lism of PBDEs (Hakk and Letcher 2003). In
this respect, it should also be noted that expo-
sure to PBDEs in children at the age of rapid
brain development is disproportionally high
(Jones-Otazu et al. 2005). The stronger Ca2+
homeostasis-disrupting effect of these hydrox-
ylated metabolites is therefore a critical factor
that should be taken into account in human
PBDE risk assessment, in particular in relation
to neurotoxicity and neurodevelopment.
Based on the mechanism of action observed in
the present study with PBDEs and those
reported earlier for ortho-substituted PCBs
(i.e., disruption of Ca2+ homeostasis), a cumu-
lative neurotoxic effect (on [Ca2+]i) of both
groups of compounds can not be ruled out.
Further research should determine whether
combined exposure to PBDEs and ortho-PCBs
is of neurotoxicologic relevance in humans.
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